Advances in Economics, Management and Political Sciences
- The Open Access Proceedings Series for Conferences
Proceedings of the 2nd International Conference on Financial Technology and Business Analysis
Series Vol. 50 , 01 December 2023
Open
Access | Article
Comparison and Research on Basic Modern Medical Systems in China and America
* Author to whom correspondence should be addressed.
Abstract
Since entering the 21st century, China's progress in modern medical systems is very obvious, and it has gradually narrowed the gap with developed countries. However, in the field of modern medicine, China's start is decades later than Western countries, so there are still some gaps. This report will start from three aspects: Sino -US modern medical system structure, medical insurance system, and medical supervision, comparing and analyzing some primary data, the following three suggestions are put forward: further, diversify the medical and health system with Chinese characteristics; improve the basic medical unit based on the community construction to reduce the waste of medical resources; simplify and improve the drug registration and approval process, to apply it to the grassroots as soon as possible. This report aims to conduct a comparative analysis of the modern medical systems in China and the United States, find solutions that can be improved, and improve the modern Chinese medical system.
Keywords
medical insurance, medical system structure, medicine structure
References
1. Ma Xudong, Hu Ruirong, Zhao Minggang. Comparison of the basic medical and health system and related conditions of China and the United States [J]. Modern hospital management, 2014,12 (2): 27-32. Doi: 10.3969/J.ISSN.1672- 4232.2014.02.010.
2. The National Health and Health Commission. 2018 China Health and Health Statistical Yearbook [M]. Beijing: China Union Medical University Press, 2018.
3. The General Office of the General Office of the Central Committee of the Communist Party of China issued the "Opinions on Further Improve the Medical and Health Service System"
4. Wang Kun, Mao Ayan, Meng Yueli, Yang Yujie, Dong Pei, & Qiu Wuqi. (2019). -805.
5. https://apps.who.int/iris/handle/10665/208229
6. Huang Luqi. (2020). Chinese and Western medicine have complementary advantages and build a sanitary system with Chinese characteristics. Science and Technology Herald, 38 (8), 1-1.
7. In 2021, my country's Health and Health Business Development Statistics Bulletin_Mctification_China Government Network (www.gov.cn)
8. Bai Yang, He Zhu, Ma Xiaochen, He Ping, Yuan Beibei, Meng Qingyue, & Xu Jin. (2020). The exploration of the American health system integration model and its revelation to our country. Research on China Health Policy, 13 (2), 46-52, 46-52.
9. Price Setting and Price Regulation in Health Care Lessons for Advancing University . Available from: https://www.researchgate.net/figure/organization-of-the- health -Care-System-IN-THE-United-States_fig38_334465645 [Accessed 16 Jul, 2023]
10. Lin Yifu. (2021). The development process and reform of the Chinese medical system. 2021− 01− 11) [2021− 01− 20]. // Finance. Sina. CN/Review/JCGC/2021 -01-11/DOC-IIZNCTKF1610411. Shtml. Lin Yf. The Development and Reform of China \ 's Healthcare System.
11. Wang Yang, Han Jianjun, & Xu Yanli. (2019). The sound of the other side of the ocean -the new American version of the junior health care quality assessment strategy to enlighten the quality evaluation system of China ’s general medical service service. China General Medicine, 22 (16) , 1889.
12. Meng Yanchen. (2020). The enlightenment of the relevant legal system in the American hospital management to the management of foreign hospitals in my country. Chinese Hospital, (1), 56-59.
13. The Practicing Physician of the People's Republic of China-Findlaw.cn
14. Continue to meet the people's growing good life needs
15. 2021 Medical Security Development Statistics Express
16. Wang Wenzheng, Zhou Yuhan, & Hou Qingfeng. (2019). Fair Research on China's basic medical insurance system. Journal of Yunnan Agricultural University: Social Science Edition, 13 (2), 65-70.
17. Song Wei, Ge Jiajia, Shu Qing, Ge Weihong, & Yao Wenbing. (2021). American Medical Insurance and Drug Therapy Management Services. Medical Herald, 40 (3), 336-339.
18. Yuan Wei. (2015). Inspection report of the US medical insurance system. China Medical Insurance, (10), 68-71.
19. Analysis of the current status of Chinese drug quality and safety management // Zhao Lindu. Medicine pain: separate drug safety and medicine. Beijing: Science Press, 2015.
20. The implementation opinions of the General Office of the State Council on comprehensively strengthening the capacity of drug supervision capabilities___2021 No. 14 State Council Communist Party_China Government Network (www.gov.cn)
21. Wang Shengpeng, Zhu Jiong, Zhang Chi, et al. Comparison of drug inspection and supervision of drugs in China [J]. Chinese Pharmaceuticals, 2020, 34 (2): 146-157.
22. Ye Jin. (2021). Research on the problem of drug safety supervision in my country (Doctral Dissertation, Nanchang: Jiangxi University of Finance and Economics)
23. Meng Xiaoqing, Ma Wenwen, Sun Qiang, and the comparative study of domestic and foreign drug quality spot check and inspection system [J]. Chinese drug evaluation, 2021, 38 (5): 375-379.
24. Wang Shengpeng, Zhu Jiong, Wang Yan. Analysis and revelation of the quality spot inspection inspection inspection inspection in the United States [J]. Modern Pharmacy in China, 2021, 38 (5): 630-635.
25. FDA. Novel Drug Approvals for 2019 [EB/OL]. (2020-01-14) [2021-01-18].
26. Cui Jiyu, & Han Youli. (2021). Research on the development strategy of anti-tumor new drugs based on the status quo of new drugs in China, the United States and Japan. China Health Policy Research, 14 (8), 52-59.
27. Zhang Liqun. (2015). 2015 Edition of "Chinese Pharmacopoeia" Overview of Pharmaceutical Pharmaceuticals. Chinese Pharmacy Magazine, 50 (20), 1754-1756.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Financial Technology and Business Analysis
- ISBN (Print)
- 978-1-83558-147-6
- ISBN (Online)
- 978-1-83558-148-3
- Published Date
- 01 December 2023
- Series
- Advances in Economics, Management and Political Sciences
- ISSN (Print)
- 2754-1169
- ISSN (Online)
- 2754-1177
- DOI
- 10.54254/2754-1169/50/20230563
- Copyright
- 01 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited